We are studying how dupilumab affects ear symptoms and hearing in patients with chronic rhinosinusitis and eosinophilic otitis media. This research aims to improve understanding of treatment benefits for these conditions.
Health conditions and diseases that the clinical trial is designed to study and treat.
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a long-term inflammation of the sinuses and nasal passages, often accompanied by the growth of polyps, leading to symptoms like nasal congestion, loss of smell, and facial pain.
Eosinophilic Otitis Media (EOM) is a condition characterized by inflammation in the middle ear, often leading to fluid accumulation and symptoms such as hearing loss and ear pain.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.